Gaithersburg, MD, United States of America

Benjamin Thomas Kibalo

This inventor holds 1 USPTO granted patent. Top assignee: Shire Laboratories, Inc.. Active years: 2004.


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Benjamin Thomas Kibalo

Introduction

Benjamin Thomas Kibalo is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of pharmaceutical products, particularly in the area of encapsulation techniques. His work has implications for the efficiency and effectiveness of oral dosage forms in the pharmaceutical industry.

Latest Patents

Kibalo holds a patent for the "Fluidization of particles for encapsulation in oral dosage pharmaceutical products." This innovative patent describes a system that includes a hopper and a dosator. The hopper is designed to receive particles with irregular geometries and sizes greater than about 100 µm for delivery to the dosator. A gaseous fluid is directed into the hopper to fluidize the particles, minimizing or eliminating voids within the particle bed. This fluidization process ensures a continuous and uniform flow of particles, resulting in encapsulated products with desirable weights and particle size distributions. He has 1 patent to his name.

Career Highlights

Kibalo is associated with Shire Laboratories, Inc., where he applies his expertise in pharmaceutical innovations. His work has contributed to advancements in the encapsulation processes that are crucial for developing effective oral dosage forms.

Collaborations

Throughout his career, Kibalo has collaborated with notable colleagues, including Amir H Shojaei and Scott A Ibrahim. These collaborations have likely enhanced the quality and impact of his work in the pharmaceutical field.

Conclusion

Benjamin Thomas Kibalo's innovative work in the encapsulation of oral dosage pharmaceutical products showcases his commitment to improving pharmaceutical technologies. His contributions are vital for the advancement of effective medication delivery systems.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…